Volkswirtschaftliches Institut
Refine
Has Fulltext
- yes (3)
Is part of the Bibliography
- yes (3)
Document Type
- Doctoral Thesis (3)
Keywords
- Innovation (3) (remove)
Institute
Sonstige beteiligte Institutionen
The aim of this thesis is to examine the competition patterns that exist between originators and generics by focusing on the articulations between regulation and incentives to innovate.
Once the characteristics of regulation in pharmaceutical markets is reviewed in the first chapter and an analysis of some current challenges related to cost-containment measures and innovation issues is performed, then in the second chapter, an empirical study is performed to investigate substitution patterns. Based on the EC´s merger decisions in the pharmaceutical sector from 1989 to 2011, this study stresses the key criteria to define the scope of the relevant product market based on substitution patterns and shows the trend towards a narrower market in time.
Chapters three and four aim to analyse in depth two widespread measures, the internal reference pricing system in off-patent markets, and risk-sharing schemes in patent-protected markets. By taking into account informational advantages of originators over generics, the third chapter shows the extent to which the implementation of a reference price for off-patent markets can contribute in promoting innovation.
Finally, in the fourth chapter, the modeling of risk-sharing schemes explains how such schemes can help in solving moral hazard and adverse selection issues by continuously giving pharmaceutical companies incentives to innovate and supplying medicinal products of a higher quality.
This thesis deals with the economics of innovation. In a general introduction we illustrate how several aspects of competition policy are linked to firms' innovation incentives. In three individual essays we analyze more specific issues. The first essay deals with interdependencies of mergers and innovation incentives. This is particularly relevant as both topics are central elements of a firm's competitive strategy. The essay focuses on the impact of mergers on innovative activity and competition in the product market. Possible inefficiencies due to organizational problems of mergers are accounted for. We show that optimal investment strategies depend on the resulting market structure and differ significantly from insider to outsider. In our linear model mergers turn out to increase social surplus. The second essay analyzes the different competitive advantages of large and small firms in innovation competition. While large firms typically have a better access to product markets, small firms often have a superior research efficiency. These distinct advantages immediately lead to the question of cooperations between firms. In our model we allow large firms to acquire small firms. In a pre-contest acquisition game large firms bid sequentially for small firms in order to combine respective advantages. Innovation competition is modeled as a patent contest. Sequential bidding allows the first large firms to bid strategically to induce a reaction of its competitor. For high efficiencies large firms prefer to acquire immediately, leading to a symmetric market structure. For low efficiencies strategic waiting of the first large firm leads to an asymmetric market structure even though the initial situation is symmetric. Furthermore, acquisitions increase the chances for successful innovation. The third essay deals with government subsidies to innovation. Government subsidies for research and development are intended to promote projects with high returns to society but too little private returns to be beneficial for private investors. Apart from the direct funding of these projects, government grants may serve as a signal of good investments for private investors. We use a simple signaling model to capture this phenomenon and allow for two types of risk classes. The agency has a preference for high risk projects as they promise high expected social returns, whereas banks prefer low risk projects with high private returns. In a setup where the subsidy can only be used to distinguish between high and low risk projects, government agency's signal is not very helpful for banks' investment decision. However, if the subsidy is accompanied by a quality signal, it may lead to increased or better selected private investments. The last chapter summarizes the main findings and presents some concluding remarks on the results of the essays.
Diese Arbeit beschäftigt sich mit Innovationsprozessen der medizintechnischen Industrie in Deutschland am Beispiel der bildgebenden Verfahren. Einen geeigneten Analyserahmen, um die komplexen Verflechtungen und Erfolgs-determinanten zu erfassen, bietet der Clusteransatz Michael Porters. Der Clusteransatz wird um wachstumstheoretische, politökonomische Ansätze ergänzt und erweitert, um die Medizintechnikbranche quantitativ und qualitativ zu untersuchen und die Wechselwirkungen zwischen Medizintechniknetzwerk, Innovationen und staatlichem Sozialsystem in Deutschland aufzuzeigen. Es wird geklärt, welche Auswirkungen Innovationen für die medizintechnische Branche haben und welche institutionellen und politischen Bedingungen Innovationen begünstigen, welche wirtschaftspolitischen Handlungsempfehlungen daraus abgeleitet werden können und wie sich die Zukunft für diese Branche gestalten könnte. Kapitel 1 spezifiziert den Untersuchungsgegenstand auf die bildgebenden Verfahren. Kapitel 2 nimmt - anhand diverser Innovationsindikatoren - eine quantitative Eingruppierung der deutschen medizintechnischen Industrie vor. In Kapitel 3 werden die bislang gewonnen Erkenntnisse mit dem Clusterkonzept Porters einer qualitativen Analyse unterzogen. Es wird der Frage nachgegangen, was die Wettbewerbsfähigkeit der Medizintechnik ausmacht. Hierbei liegt ein Schwerpunkt auf den Wechselbeziehungen von Medizin-technikbranche und staatlichem Gesundheitssystem. Kapitel 4 ergänzt die Wettbewerbsfähigkeitsanalyse um einen inter-industriellen Vergleich. Weitere international erfolgreiche deutsche Branchen werden in ihren Erfolgsfaktoren mit der Medizintechnik verglichen. Das Konzept der "Langen Wellen" präzisiert die Spezifika der Medizintechnikbranche. Kapitel 5 fasst die Ergebnisse der Untersuchung zusammen und gibt eine Prognose für die mögliche Zukunftsentwicklung der Branche.